StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Regeneron Pharma (REGN) PT Raised to $684 at Cowen
August 6, 2020 8:13 AM
Cowen analyst Yaron Werber raised the price target on Regeneron Pharma (NASDAQ: REGN) to $684.00 (from $584.00) while ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Analyst PT Change
Next Articles
Regeneron Pharma (REGN) PT Raised to $675 at Barclays
August 6, 2020 6:30 AM
Regeneron (REGN) Tops Q2 EPS by $1.18, Revenues Beat
August 5, 2020 6:39 AM
Regeneron Reports Second Quarter 2020 Financial and Operating Results
August 5, 2020 6:30 AM